What is Boston Scientific's specialty pharmaceuticals — goodwill?

Boston Scientific (BSX) reported specialty pharmaceuticals — goodwill of $236.00M in Q4 2021.

What does specialty pharmaceuticals — goodwill mean?

The value of intangible assets like brand and market position acquired through past business purchases in the Specialty Pharmaceuticals segment.

Discontinued — last reported Q4 '21

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ4 2018

Last reportedQ4 2021

Rolls up toGoodwill

An increase suggests recent acquisitions, while a decrease may indicate impairment or divestiture.

Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinat...

Commonly reported by medical device and pharmaceutical firms as 'Goodwill' under segment notes.

Metric ID: bsx_segment_specialty_pharmaceuticals_goodwill

1 periods

	Q4 '21
Value	$236.00M

What is Boston Scientific's specialty pharmaceuticals — goodwill?: Boston Scientific (BSX) reported specialty pharmaceuticals — goodwill of $236.00M in Q4 2021.
What does specialty pharmaceuticals — goodwill mean?: The value of intangible assets like brand and market position acquired through past business purchases in the Specialty Pharmaceuticals segment.